LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "resectable non" as a keyword



Optimizing Pre‐Operative Clinical Staging in Resectable Non‐Small Cell Lung Cancer (NSCLC): A Retrospective Cohort Study

Sign Up to like & get
recommendations! Published in 2025 at "Thoracic Cancer"

DOI: 10.1111/1759-7714.70108

Abstract: Accurate pre‐operative clinical staging is essential for guiding treatment in resectable non‐small cell lung cancer (NSCLC). Discrepancies between clinical and pathological staging raise concerns about treatment appropriateness. This study aimed to assess staging accuracy, identify… read more here.

Keywords: cancer; non small; clinical staging; operative clinical ... See more keywords

A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review

Sign Up to like & get
recommendations! Published in 2024 at "Journal of Oncology Pharmacy Practice"

DOI: 10.1177/10781552241260864

Abstract: Objective The objective of this article is to review the efficacy, safety, and evidence for current use and potential future uses of immune-checkpoint inhibitors (ICIs) in the management of resectable non-small cell lung cancer (NSCLC).… read more here.

Keywords: non small; review; immune checkpoint; small cell ... See more keywords

Neoadjuvant immunotherapy in resectable non-small-cell lung cancer

Sign Up to like & get
recommendations! Published in 2023 at "Therapeutic Advances in Medical Oncology"

DOI: 10.1177/17588359231163798

Abstract: The advent of immune checkpoint inhibition has pushed the treatment paradigm for resectable non-small-cell lung cancer (NSCLC) toward neoadjuvant therapy. A growing number of promising trials have examined the utility of neoadjuvant immunotherapy, both alone… read more here.

Keywords: resectable non; non small; immunotherapy; neoadjuvant immunotherapy ... See more keywords

Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung cancer

Sign Up to like & get
recommendations! Published in 2022 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2022.984666

Abstract: This study evaluated the efficacy of neoadjuvant immunochemotherapy (Io+Chemo) versus chemotherapy alone (Chemo) in resectable non–small cell lung cancer (NSCLC) in a real-world setting. The association of tumor immune microenvironment (TIME) with pathologic response to… read more here.

Keywords: resectable non; cell; non small; neoadjuvant immunochemotherapy ... See more keywords

Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis

Sign Up to like & get
recommendations! Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.901494

Abstract: Background It remains uncertain whether neoadjuvant immune checkpoint inhibitor (nICI) is superior to neoadjuvant chemotherapy (nCT) in resectable non-small cell lung cancer. In addition, there are outstanding questions for nICI such as the ideal treatment… read more here.

Keywords: resectable non; neoadjuvant chemotherapy; non small; arm ... See more keywords

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series

Sign Up to like & get
recommendations! Published in 2022 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2022.912153

Abstract: Background: Evidence of osimertinib as neoadjuvant therapy for resectable non-small cell lung cancer (NSCLC) are currently lacking. This case series study aimed to assess the safety and feasibility of neoadjuvant osimertinib therapy followed by surgery… read more here.

Keywords: resectable non; neoadjuvant therapy; non small; therapy resectable ... See more keywords

Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer

Sign Up to like & get
recommendations! Published in 2023 at "Pharmaceuticals"

DOI: 10.3390/ph16020233

Abstract: The neoadjuvant use of immune checkpoint inhibitors (ICI) in resectable non-small cell lung cancer (NSCLC) is being increasingly adopted, but questions about the most appropriate applications remain. Although patients with resectable NSCLC are often treated… read more here.

Keywords: resectable non; non small; checkpoint inhibitors; immune checkpoint ... See more keywords